BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Freedman BI, Moxey-Mims MM, Alexander AA, Astor BC, Birdwell KA, Bowden DW, Bowen G, Bromberg J, Craven TE, Dadhania DM, Divers J, Doshi MD, Eidbo E, Fornoni A, Gautreaux MD, Gbadegesin RA, Gee PO, Guerra G, Hsu CY, Iltis AS, Jefferson N, Julian BA, Klassen DK, Koty PP, Langefeld CD, Lentine KL, Ma L, Mannon RB, Menon MC, Mohan S, Moore JB, Murphy B, Newell KA, Odim J, Ortigosa-Goggins M, Palmer ND, Park M, Parsa A, Pastan SO, Poggio ED, Rajapakse N, Reeves-Daniel AM, Rosas SE, Russell LP, Sawinski D, Smith SC, Spainhour M, Stratta RJ, Weir MR, Reboussin DM, Kimmel PL, Brennan DC. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale. Kidney Int Rep 2020;5:278-88. [PMID: 32154449 DOI: 10.1016/j.ekir.2019.11.022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Friedman DJ, Ma L, Freedman BI. Treatment potential in APOL1-associated nephropathy. Current Opinion in Nephrology & Hypertension 2022;31:442-8. [DOI: 10.1097/mnh.0000000000000816] [Reference Citation Analysis]
2 Pullen LC. Targeting Inequities in Kidney Transplantation. Am J Transplant 2022;22:1937-8. [PMID: 35920144 DOI: 10.1111/ajt.16667] [Reference Citation Analysis]
3 Doshi MD, Schaubel DE, Xu Y, Rao PS, Sung RS. Clinical Utility in Adopting Race-free Kidney Donor Risk Index. Transplant Direct 2022;8:e1343. [PMID: 35747522 DOI: 10.1097/TXD.0000000000001343] [Reference Citation Analysis]
4 Thongprayoon C, Vaitla P, Jadlowiec CC, Leeaphorn N, Mao SA, Mao MA, Pattharanitima P, Bruminhent J, Khoury NJ, Garovic VD, Cooper M, Cheungpasitporn W. Use of Machine Learning Consensus Clustering to Identify Distinct Subtypes of Black Kidney Transplant Recipients and Associated Outcomes. JAMA Surg 2022;:e221286. [PMID: 35507356 DOI: 10.1001/jamasurg.2022.1286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Soraru J, Chakera A, Isbel N, Mallawaarachichi A, Rogers N, Trnka P, Patel C, Mallett A. The evolving role of diagnostic genomics in kidney transplantation. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.05.019] [Reference Citation Analysis]
6 Harris DD, Fleishman A, Pavlakis M, Pollak MR, Baliga PK, Rohan V, Kayler LK, Rodrigue JR. Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and Nonpatients. J Surg Res 2022;277:116-24. [PMID: 35489216 DOI: 10.1016/j.jss.2022.04.011] [Reference Citation Analysis]
7 Divers J, Mohan S, Brown WM, Pastan SO, Israni AK, Gaston RS, Bray R, Islam S, Sakhovskaya NV, Mena-Gutierrez AM, Reeves-Daniel AM, Julian BA, Freedman BI. Employment status at transplant influences ethnic disparities in outcomes after deceased donor kidney transplantation. BMC Nephrol 2022;23:6. [PMID: 34979953 DOI: 10.1186/s12882-021-02631-4] [Reference Citation Analysis]
8 Freedman BI, Mena-Gutierrez AM, Ma L. Recipient APOL1 Genotype Effects on Outcomes After Kidney Transplantation. Am J Kidney Dis 2021:S0272-6386(21)00995-1. [PMID: 34801598 DOI: 10.1053/j.ajkd.2021.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Malone AF. APOL1 risk variants in kidney transplantation: a modulation of immune cell function. J Clin Invest 2021;131:e154676. [PMID: 34779415 DOI: 10.1172/JCI154676] [Reference Citation Analysis]
10 Uffing A, Hullekes F, Riella LV, Hogan JJ. Recurrent Glomerular Disease after Kidney Transplantation: Diagnostic and Management Dilemmas. Clin J Am Soc Nephrol 2021;16:1730-42. [PMID: 34686531 DOI: 10.2215/CJN.00280121] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Lentine KL, Mannon RB. Apolipoprotein L1: role in the evaluation of kidney transplant donors. Curr Opin Nephrol Hypertens 2020;29:645-55. [PMID: 33009133 DOI: 10.1097/MNH.0000000000000653] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
12 Leeaphorn N, Thongprayoon C, Vaitla P, Hansrivijit P, Jadlowiec CC, Mao SA, Chewcharat A, Katari S, Pattharanitima P, Boonpheng B, Kaewput W, Mao MA, Cooper M, Cheungpasitporn W. Outcomes of Kidney Transplant Recipients with Sickle Cell Disease: An Analysis of the 2000-2019 UNOS/OPTN Database. J Clin Med 2021;10:3063. [PMID: 34300230 DOI: 10.3390/jcm10143063] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Wen J, Xie M, Rowland B, Rosen JD, Sun Q, Chen J, Tapia AL, Qian H, Kowalski MH, Shan Y, Young KL, Graff M, Argos M, Avery CL, Bien SA, Buyske S, Yin J, Choquet H, Fornage M, Hodonsky CJ, Jorgenson E, Kooperberg C, Loos RJF, Liu Y, Moon JY, North KE, Rich SS, Rotter JI, Smith JA, Zhao W, Shang L, Wang T, Zhou X, Reiner AP, Raffield LM, Li Y. Transcriptome-Wide Association Study of Blood Cell Traits in African Ancestry and Hispanic/Latino Populations. Genes (Basel) 2021;12:1049. [PMID: 34356065 DOI: 10.3390/genes12071049] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Freedman BI, Poggio ED. APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro). Kidney Int 2021;100:27-30. [PMID: 34154719 DOI: 10.1016/j.kint.2020.11.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Cerdeña JP, Tsai J, Grubbs V. APOL1, Black Race, and Kidney Disease: Turning Attention to Structural Racism. American Journal of Kidney Diseases 2021;77:857-60. [DOI: 10.1053/j.ajkd.2020.11.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Freedman BI, Burke W, Divers J, Eberhard L, Gadegbeku CA, Gbadegesin R, Hall ME, Jones-Smith T, Knight R, Kopp JB, Kovesdy CP, Norris KC, Olabisi OA, Roberts GV, Sedor JR, Blacksher E. Diagnosis, Education, and Care of Patients with APOL1-Associated Nephropathy: A Delphi Consensus and Systematic Review. J Am Soc Nephrol 2021:ASN. [PMID: 33853887 DOI: 10.1681/ASN.2020101399] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Freedman BI, Kopp JB, Sampson MG, Susztak K. APOL1 at 10 years: progress and next steps. Kidney Int 2021;99:1296-302. [PMID: 33794228 DOI: 10.1016/j.kint.2021.03.013] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
18 Yusuf AA, Govender MA, Brandenburg JT, Winkler CA. Kidney disease and APOL1. Hum Mol Genet 2021;30:R129-37. [PMID: 33744923 DOI: 10.1093/hmg/ddab024] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
19 Bruggeman LA, Sedor JR, O'Toole JF. Apolipoprotein L1 and mechanisms of kidney disease susceptibility. Curr Opin Nephrol Hypertens 2021;30:317-23. [PMID: 33767059 DOI: 10.1097/MNH.0000000000000704] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Roberts BT, Rodgers GP. NIDDK initiatives addressing health disparities in chronic diseases. J Clin Invest 2020;130:5036-8. [PMID: 32692729 DOI: 10.1172/JCI141563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ekwenna O, Lang J, Thomas I. APOL1 screening of potential living kidney donors in resource-limited countries: an initial experience in Antigua & Barbuda and Nigeria. Transpl Int 2021;34:590-2. [PMID: 33423344 DOI: 10.1111/tri.13815] [Reference Citation Analysis]
22 Ortigosa-Goggins M, Garg AX, Li L, Doshi MD. Donor Family History of ESKD and Long-term Outcomes Among African American Living Kidney Donors: A Retrospective Cohort Study. Kidney Med 2021;3:223-230.e1. [PMID: 33851117 DOI: 10.1016/j.xkme.2020.11.013] [Reference Citation Analysis]
23 Tuttle KR, Knight R, Appelbaum PS, Arora T, Bansal S, Bebiak J, Brown K, Campbell C, Cooperman L, Corona-Villalobos CP, Dighe A, de Boer IH, Hall DE, Jefferson N, Jolly S, Kermani A, Lee SC, Mehl K, Murugan R, Roberts GV, Rosas SE, Himmelfarb J, Miller RT; Kidney Precision Medicine Project. Integrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine Project. Clin J Am Soc Nephrol 2021;16:660-8. [PMID: 33257411 DOI: 10.2215/CJN.10270620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Shetty AA, Tawhari I, Safar-Boueri L, Seif N, Alahmadi A, Gargiulo R, Aggarwal V, Usman I, Kisselev S, Gharavi AG, Kanwar Y, Quaggin SE. COVID-19-Associated Glomerular Disease. J Am Soc Nephrol 2021;32:33-40. [PMID: 33214201 DOI: 10.1681/ASN.2020060804] [Cited by in Crossref: 31] [Cited by in F6Publishing: 58] [Article Influence: 15.5] [Reference Citation Analysis]
25 Quinlan C. The Future of Paediatric Nephrology—Genomics and Personalised Precision Medicine. Curr Pediatr Rep 2020;8:115-21. [DOI: 10.1007/s40124-020-00218-5] [Reference Citation Analysis]
26 Garg AX, Levey AS, Kasiske BL, Cheung M, Lentine KL; KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors Work Group and Evidence Review Team. Application of the 2017 KDIGO Guideline for the Evaluation and Care of Living Kidney Donors to Clinical Practice. Clin J Am Soc Nephrol 2020;15:896-905. [PMID: 32276946 DOI: 10.2215/CJN.12141019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
27 Fuentes F, Kopp JB. Launching APOLLO: The Role of APOL1 Genetic Variants in Live- and Deceased-Donor Kidney Transplantation. Kidney Int Rep 2020;5:252-4. [PMID: 32154807 DOI: 10.1016/j.ekir.2019.12.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]